This Drug Could Prevent PAH in People with Scleroderma
source: shutterstock.com

This Drug Could Prevent PAH in People with Scleroderma

According to a story from Scleroderma News, findings from the recent Phase 2 EDITA clinical trial suggested that ambrisentan (marketed as Letairis), which is approved to treat pulmonary arterial hypertension…

Continue Reading This Drug Could Prevent PAH in People with Scleroderma
Higher PLR and PHR Linked to Worse Systemic Sclerosis Activity
A case of systemic sclerosis. Source: Nevit Dilmen / CC BY-SA (https://creativecommons.org/licenses/by-sa/3.0)

Higher PLR and PHR Linked to Worse Systemic Sclerosis Activity

  Although the medical field has made significant strides over the years, there is still a lot we don’t know about the body. For example, what can we learn about…

Continue Reading Higher PLR and PHR Linked to Worse Systemic Sclerosis Activity
June is Scleroderma Awareness Month: Spreading Rare Disease Awareness
source: pixabay.com

June is Scleroderma Awareness Month: Spreading Rare Disease Awareness

According to a story from Scleroderma News, June is recognized as Scleroderma Awareness Month. While physical distancing as a result of the ongoing coronavirus/COVID-19 pandemic may keep some folks at…

Continue Reading June is Scleroderma Awareness Month: Spreading Rare Disease Awareness